| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.05 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.06 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.06 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.089 | 0.06 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.07 |